Adage Capital Partners’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
+304,200
| New | +$13.3M | 0.02% | 555 |
|
|
2022
Q2 | – | Sell |
-180,000
| Closed | -$7.62M | – | 1116 |
|
|
2022
Q1 | $7.62M | Sell |
180,000
-25,000
| -12% | -$1.06M | 0.01% | 768 |
|
|
2021
Q4 | $13M | Sell |
205,000
-45,000
| -18% | -$2.86M | 0.02% | 624 |
|
|
2021
Q3 | $14.7M | Buy |
250,000
+150,000
| +150% | +$8.81M | 0.03% | 573 |
|
|
2021
Q2 | $4.85M | Hold |
100,000
| – | – | 0.01% | 830 |
|
|
2021
Q1 | $3.89M | Hold |
100,000
| – | – | 0.01% | 823 |
|
|
2020
Q4 | $6.2M | Sell |
100,000
-150,000
| -60% | -$9.3M | 0.01% | 665 |
|
|
2020
Q3 | $8.08M | Buy |
+250,000
| New | +$8.08M | 0.02% | 563 |
|